Medtronic has gained FDA approval for its Endurant II Aorto-Uni-Iliac Stent Graft, designed to treat abdominal aortic or aorto-iliac aneurysm patients who cannot be treated with a bifurcated device. The firm also earned 510(k) clearance for its Sentrant Introducer Sheath, which allows passage of stent grafts from the access site in the femoral artery to the therapy site.

Related Summaries